Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation-Reference-Cited by-同舟云学术

Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation

Published:2021-05-10 Issue:9 Volume:76 Page:2840-2854
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Khaitov Musa¹^ORCID,Nikonova Alexandra¹²^ORCID,Shilovskiy Igor¹^ORCID,Kozhikhova Ksenia¹^ORCID,Kofiadi Ilya¹^ORCID,Vishnyakova Lyudmila¹,Nikolskii Alexander¹^ORCID,Gattinger Pia³^ORCID,Kovchina Valeria¹^ORCID,Barvinskaia Ekaterina¹,Yumashev Kirill¹,Smirnov Valeriy¹,Maerle Artem¹^ORCID,Kozlov Ivan¹,Shatilov Artem¹,Timofeeva Anastasiia¹,Andreev Sergey¹,Koloskova Olesya¹^ORCID,Kuznetsova Nadezhda⁴,Vasina Daria⁴^ORCID,Nikiforova Maria⁴^ORCID,Rybalkin Sergei¹,Sergeev Ilya¹,Trofimov Dmitriy¹,Martynov Alexander¹,Berzin Igor⁵,Gushchin Vladimir⁴^ORCID,Kovalchuk Aleksey⁶,Borisevich Sergei⁶^ORCID,Valenta Rudolf¹³^ORCID,Khaitov Rakhim¹^ORCID,Skvortsova Veronica⁵

Affiliation:

1. NRC Institute of Immunology FMBA Moscow Russia

2. Mechnikov Research Institute for Vaccines and Sera Moscow Russia

3. Medical University of Vienna Vienna Austria

4. Federal State Budget Institution “National Research Centre for Epidemiology and Microbiology named after Honorary Academician N. F.Gamaleya” of the Ministry of Health of the Russian Federation Moscow Russia

5. Federal Medico‐biological Agency of Russia (FMBA Russia) Moscow Russia

6. 48 Central Research Institute of the Ministry of Defense of the Russian Federation Moscow Russia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14850

Reference65 articles.

1. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

2. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

3. The hallmarks of COVID-19 disease